Imhoff John E bought GTHP
March 7, 2025 · Form 4 insider transaction
Imhoff John E bought 286 shares of Guided Therapeutics, Inc., a transaction worth N/A. The trade was recorded as open-market purchase and disclosed on an SEC Form 4.
Direction
Acquired (buy-side)
Shares
286
Price
N/A
Total value
N/A
InsiderImhoff John E
RoleDirector, 10% owner
SecurityPreferred Series C Stock
Transaction codeP: Open-market purchase
Transaction dateMarch 7, 2025
Filing dateApril 17, 2025
Shares owned after286
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
On March 7, 2025, for a purchase price of $112,934.50, Mr. Imhoff purchased 286 shares of Series C preferred stock from a third party. The shares had a conversion price of $0.1266, and on March 11, 2025 were converted to 2,258,690 common shares.